Hypermarcas (OTCMKTS:HYPMY) Share Price Crosses Below 50 Day Moving Average – Time to Sell?

Shares of Hypermarcas (OTCMKTS:HYPMY) passed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $4.20 and traded as low as $4.16. Hypermarcas shares last traded at $4.16, with a volume of 867 shares trading hands.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on HYPMY shares. Jefferies Financial Group raised shares of Hypermarcas to a “strong-buy” rating in a research note on Monday. Zacks Research upgraded Hypermarcas to a “hold” rating in a report on Wednesday, April 29th. One analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, Hypermarcas has an average rating of “Buy”.

Hypermarcas Stock Performance

The stock’s 50-day simple moving average is $4.18 and its 200-day simple moving average is $4.39. The firm has a market capitalization of $2.81 billion, a PE ratio of 8.32 and a beta of 0.71.

Hypermarcas (OTCMKTS:HYPMY) last posted its earnings results on Wednesday, April 29th. The company reported $0.10 EPS for the quarter. The firm had revenue of $383.13 million during the quarter. Hypermarcas had a net margin of 19.41% and a return on equity of 14.08%. As a group, analysts predict that Hypermarcas will post 0.53 earnings per share for the current fiscal year.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.